[go: up one dir, main page]

DE69837996D1 - Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta - Google Patents

Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta

Info

Publication number
DE69837996D1
DE69837996D1 DE69837996T DE69837996T DE69837996D1 DE 69837996 D1 DE69837996 D1 DE 69837996D1 DE 69837996 T DE69837996 T DE 69837996T DE 69837996 T DE69837996 T DE 69837996T DE 69837996 D1 DE69837996 D1 DE 69837996D1
Authority
DE
Germany
Prior art keywords
tnfr
methods
beta
alpha
factor receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69837996T
Other languages
English (en)
Other versions
DE69837996T2 (de
Inventor
Reiner L Gentz
Jian Ni
Reinhard Ebner
Guo-Liang Yu
Steven M Ruben
Ping Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21883066&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69837996(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of DE69837996D1 publication Critical patent/DE69837996D1/de
Publication of DE69837996T2 publication Critical patent/DE69837996T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69837996T 1997-01-14 1998-01-13 Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta Expired - Fee Related DE69837996T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3549697P 1997-01-14 1997-01-14
US35496P 1997-01-14
PCT/US1998/000153 WO1998030694A2 (en) 1997-01-14 1998-01-13 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)

Publications (2)

Publication Number Publication Date
DE69837996D1 true DE69837996D1 (de) 2007-08-09
DE69837996T2 DE69837996T2 (de) 2008-02-28

Family

ID=21883066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837996T Expired - Fee Related DE69837996T2 (de) 1997-01-14 1998-01-13 Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta

Country Status (12)

Country Link
US (2) US8003386B1 (de)
EP (1) EP1007659B1 (de)
JP (1) JP2001507937A (de)
KR (1) KR20000070174A (de)
CN (1) CN1247567A (de)
AT (1) ATE365796T1 (de)
AU (1) AU729062C (de)
BR (1) BR9806954A (de)
CA (1) CA2277925A1 (de)
DE (1) DE69837996T2 (de)
ES (1) ES2286843T3 (de)
WO (1) WO1998030694A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597886B2 (en) 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US7888466B2 (en) 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
WO1997033904A1 (en) 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
US6713061B1 (en) 1996-03-12 2004-03-30 Human Genome Sciences, Inc. Death domain containing receptors
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
WO2000053755A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of tumor
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
ES2286843T3 (es) 1997-01-14 2007-12-01 Human Genome Sciences, Inc. Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
WO1999004001A1 (en) * 1997-07-21 1999-01-28 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-5
AU8767698A (en) * 1997-08-06 1999-03-01 Procter & Gamble Company, The Novel orphan receptor
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
ES2306480T3 (es) 1997-09-18 2008-11-01 Genentech, Inc. Polipeptido dcr3, un homologo de tnfr.
AU1535699A (en) * 1997-11-24 1999-06-15 Apotech S.A. Novel receptors opg-2
AU1541699A (en) * 1997-12-16 1999-07-05 Incyte Pharmaceuticals, Inc. Human tumor necrosis factor-r2-like proteins
DE19809978A1 (de) * 1998-03-09 1999-09-16 Basf Ag Neuer Rezeptor aus der menschlichen Lunge
CN1303429A (zh) * 1998-03-30 2001-07-11 伊莱利利公司 TNF受体超家族的成员成熟FLINT(mFLINT)多肽或OPG3的药学应用
US6916907B1 (en) * 1998-10-23 2005-07-12 Curagen Corporation Nucleic acids encoding osteoprotegern-like proteins and methods of using same
PE20001388A1 (es) * 1998-12-09 2000-12-15 Lilly Co Eli Composiciones de flint y usos de estas
CA2358508A1 (en) * 1998-12-22 2000-06-29 Eli Lilly And Company Therapeutic applications of flint polypeptides
WO2000046247A1 (en) * 1999-02-05 2000-08-10 Merck & Co., Inc. Methods of use for dna molecules encoding m68, a tnf receptor-related protein
EP2357192A1 (de) 1999-02-26 2011-08-17 Human Genome Sciences, Inc. Menschliches alpha-Endokin und Verfahren zu seiner Verwendung
MXPA01008936A (es) * 1999-03-04 2003-07-21 Human Genome Sciences Inc Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
EP1165780A2 (de) * 1999-03-30 2002-01-02 Eli Lilly And Company Flint-polypeptidanaloge
US6965012B1 (en) * 1999-03-30 2005-11-15 Eli Lilly And Company Flint polypeptide analogs
US6835814B1 (en) 1999-03-30 2004-12-28 Eli Lilly And Company Protease resistant flint analogs
JP4590504B2 (ja) * 1999-03-30 2010-12-01 イーライ リリー アンド カンパニー プロテアーゼ耐性ｆｌｉｎｔ類似体
US6627199B1 (en) 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
CA2381284A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Fhm, a novel member of the tnf ligand supergene family
WO2001010908A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU6891800A (en) * 1999-09-10 2001-04-10 Eli Lilly And Company Flint analog compounds and formulations thereof
WO2001018041A2 (en) * 1999-09-10 2001-03-15 Eli Lilly And Company Flint proteins and formulations thereof
EP1214411A2 (de) * 1999-09-10 2002-06-19 Eli Lilly And Company Flint-analoge und diese enthaltende zusammensetzungen
CA2413160A1 (en) 2000-06-15 2001-12-20 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
CA2407910C (en) 2000-06-16 2013-03-12 Steven M. Ruben Antibodies that immunospecifically bind to blys
CN1331125A (zh) * 2000-06-26 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人含细胞色素c结构域的tnfr/ngfr蛋白9.02和编码这种多肽的多核苷酸
CA2420593A1 (en) * 2000-08-25 2002-03-07 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6.alpha. and 6.beta.
MXPA03010747A (es) 2001-05-25 2004-03-02 Human Genome Sciences Inc Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
JP5424521B2 (ja) 2001-12-21 2014-02-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド アルブミン融合タンパク質
DK1543038T4 (da) * 2002-09-11 2020-11-09 Genentech Inc Proteinoprensning
NZ597082A (en) 2005-10-13 2013-11-29 Human Genome Sciences Inc Methods and Compositions for Use in Treatment of Patients with Autoantibody Positive Diseases
WO2007076465A2 (en) * 2005-12-23 2007-07-05 Diadexus, Inc. Cln248 antibody compositions and methods of use
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
CN103641918A (zh) * 2009-03-13 2014-03-19 宾夕法尼亚大学董事会 Ox40/trail融合蛋白
TWI589587B (zh) 2010-11-19 2017-07-01 衛材Ｒ＆Ｄ企管股份有限公司 中和性抗－ｃｃｌ２０抗體
US10633449B2 (en) 2013-03-27 2020-04-28 Cedars-Sinai Medical Center Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
WO2014186877A1 (en) 2013-05-24 2014-11-27 Uger Marni Diane FasR ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
EP3022295A4 (de) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signatur des tl1a (tnfsf15)-signalweges
KR20240095481A (ko) 2016-03-17 2024-06-25 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
EP0510691B1 (de) 1991-04-26 2004-11-03 Osaka Bioscience Institute Für ein menschliches Zelloberflächen-Antigen kodierende DNS
AU705114B2 (en) 1993-10-14 1999-05-13 Immunex Corporation Fas antagonists and uses thereof
US5830469A (en) 1993-10-14 1998-11-03 Immunex Corporation Fas antagonists and uses thereof
US5663070A (en) 1993-11-15 1997-09-02 Lxr Biotechnology Inc. Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
US5741667A (en) 1994-05-27 1998-04-21 Genentech, Inc. Tumor necrosis factor receptor-associated factors
US5632994A (en) 1994-06-14 1997-05-27 La Jolla Cancer Research Foundation Fas associated proteins
AU2363695A (en) 1995-04-27 1996-11-18 Human Genome Sciences, Inc. Human tumor necrosis factor receptors
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
WO2000053755A2 (en) 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of tumor
ES2286843T3 (es) 1997-01-14 2007-12-01 Human Genome Sciences, Inc. Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
WO1998056892A1 (en) 1997-06-11 1998-12-17 Human Genome Sciences, Inc. Human tumor necrosis factor receptor tr9
WO1999004001A1 (en) 1997-07-21 1999-01-28 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-5
AU8767698A (en) 1997-08-06 1999-03-01 Procter & Gamble Company, The Novel orphan receptor
WO1999011791A2 (en) 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
ES2306480T3 (es) * 1997-09-18 2008-11-01 Genentech, Inc. Polipeptido dcr3, un homologo de tnfr.
AU1535699A (en) 1997-11-24 1999-06-15 Apotech S.A. Novel receptors opg-2
AU1541699A (en) 1997-12-16 1999-07-05 Incyte Pharmaceuticals, Inc. Human tumor necrosis factor-r2-like proteins
WO1999033980A2 (en) 1997-12-30 1999-07-08 Chiron Corporation Members of tnf and tnfr families
US6297367B1 (en) 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
DE19809978A1 (de) 1998-03-09 1999-09-16 Basf Ag Neuer Rezeptor aus der menschlichen Lunge
CN1303429A (zh) 1998-03-30 2001-07-11 伊莱利利公司 TNF受体超家族的成员成熟FLINT(mFLINT)多肽或OPG3的药学应用
JP2002519062A (ja) 1998-07-06 2002-07-02 シェーリング コーポレイション 哺乳動物遺伝子；樹状細胞プロスタグランジン様トランスポーター（ｄｃ−ｐｇｔ）、ｈｄｔｅａ，ｈｓｌｊｄ３７ｒおよびｒａｎｋｌ、ｈｃｃ５ケモカイン、脱ユビキチン化１１および１２（ｄｕｂ１１、ｄｕｂ１２）、ｍｄ−１、ｍｄ−２およびサイクリンｅ２、関連試薬および方法
JP3695642B2 (ja) 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
PE20001388A1 (es) 1998-12-09 2000-12-15 Lilly Co Eli Composiciones de flint y usos de estas
CA2358508A1 (en) 1998-12-22 2000-06-29 Eli Lilly And Company Therapeutic applications of flint polypeptides
WO2000046247A1 (en) 1999-02-05 2000-08-10 Merck & Co., Inc. Methods of use for dna molecules encoding m68, a tnf receptor-related protein
MXPA01008936A (es) 1999-03-04 2003-07-21 Human Genome Sciences Inc Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
JP2004516227A (ja) 1999-03-08 2004-06-03 ジェネンテック・インコーポレーテッド 免疫関連疾患を治療するための組成物と方法
CA2367315A1 (en) 1999-03-11 2000-09-14 Human Genome Sciences, Inc. Apoptosis inducing molecule ii and methods of use
EP1165780A2 (de) 1999-03-30 2002-01-02 Eli Lilly And Company Flint-polypeptidanaloge
JP4590504B2 (ja) 1999-03-30 2010-12-01 イーライ リリー アンド カンパニー プロテアーゼ耐性ｆｌｉｎｔ類似体
CA2384713A1 (en) 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
EP1225908A2 (de) 1999-10-20 2002-07-31 Eli Lilly And Company Therapeutische verwendungen von flint polypeptiden
EP1244783A1 (de) 1999-12-07 2002-10-02 Eli Lilly And Company Verbesserte stabilität von flint durch o-glykosylierung
WO2001042434A1 (en) 1999-12-09 2001-06-14 Merck & Co., Inc. Dna molecules encoding human nhl, a dna helicase
WO2001068911A2 (en) 2000-03-15 2001-09-20 Epigenomics Ag Diagnosis of diseases associated with the cell cycle
AU2001266787A1 (en) 2000-06-07 2002-01-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1294947A2 (de) 2000-06-30 2003-03-26 Epigenomics AG Verfahren und nukleinsäuren für die pharmakogenomische methyllationsanalyse
WO2002009668A2 (en) 2000-08-02 2002-02-07 Eli Lilly And Company Pulmonary administration of flint
WO2002060317A2 (en) 2001-01-30 2002-08-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20040176279A1 (en) 2001-02-01 2004-09-09 Nigel Jenkins Flint glycoforms
WO2002060947A2 (en) 2001-02-01 2002-08-08 Eli Lilly And Company Glycoforms a fas ligand inhibitory protein analog
AU2002311787A1 (en) 2001-03-28 2002-10-15 Zycos Inc. Translational profiling
FR2908832B1 (fr) 2006-11-20 2011-08-26 Valeo Systemes Thermiques Carter pour echangeur de chaleur

Also Published As

Publication number Publication date
DE69837996T2 (de) 2008-02-28
AU729062C (en) 2004-03-25
EP1007659B1 (de) 2007-06-27
KR20000070174A (ko) 2000-11-25
ES2286843T3 (es) 2007-12-01
EP1007659A2 (de) 2000-06-14
BR9806954A (pt) 2000-03-21
US7186800B1 (en) 2007-03-06
WO1998030694A3 (en) 1998-11-12
WO1998030694A2 (en) 1998-07-16
ATE365796T1 (de) 2007-07-15
CA2277925A1 (en) 1998-07-16
US8003386B1 (en) 2011-08-23
CN1247567A (zh) 2000-03-15
AU5815798A (en) 1998-08-03
AU729062B2 (en) 2001-01-25
JP2001507937A (ja) 2001-06-19

Similar Documents

Publication Publication Date Title
DE69837996D1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE69841140D1 (de) Interleukin-17 rezeptor-ähnliches protein
DE69635088D1 (de) NEUTROKIN alpha
WO1998031806A3 (en) Fc receptors and polypeptides
NZ510367A (en) Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector
DE69836956D1 (de) Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
DE69834027D1 (de) Tumor-nekrose-faktor rezeptor 5
EP1015468A4 (de) Follistatin-3
EP1003767A4 (de) Menschlicher tumornekrosefaktor-rezeptor tr10
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
WO2000043493A8 (en) Metalloproteinase adam 22
WO2000056405A3 (en) Human tumor necrosis factor receptor-like 2
WO2000067793A8 (en) Death domain containing receptor 4
ATE472599T1 (de) Chemokin alpha-5
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
EP1187842A4 (de) Der tr10 rezeptor des menschlichen tumor-nekrose-faktors
WO1998053069A3 (en) Gdnf receptors
WO2002018622A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
WO2001032128A3 (en) Human chemokine beta-13
WO2001005834A9 (en) Human tumor necrosis factor receptors tr13 and tr14
WO2000039136A3 (en) Human brainiac-5
EP1712631A3 (de) Fc Rezeptoren
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2002057421A3 (en) Human tumor necrosis factor receptors tr13 and tr14

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee